Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Xinzhenghe Pharmaceutical Technology is a high-tech enterprise based in Chengdu, China, specializing in the research, development, and technical services of innovative small molecule drugs and high-end generic pharmaceuticals. Established in 2014 and headquartered in the Tianfu Life Science Park, the company provides comprehensive CRO and CDMO services, including lead compound optimization, process chemistry, and impurity analysis. Xinzhenghe leverages its expertise in chemical synthesis to support global pharmaceutical companies in accelerating drug development from discovery to commercialization. The company's technical team is led by experienced professionals with backgrounds in medicinal chemistry and pharmaceutical engineering. In addition to its service offerings, Xinzhenghe engages in the independent development and production of key pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company is recognized for its high standards in quality control and its ability to handle complex chemical transformations for various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 成都心正合医药科技.